The observational study included more than 4,000 patients. The video-based decision aids were given to patients, who could watch the videos alone or with their families.
The study found that for patient with medically treated BPH — those who were already receiving prescription medications — the rate of surgical intervention for BPH declined by 32 percent; but for those with untreated BPH, the rate didn’t drop significantly. For patients with localized prostate cancer, rates of active treatment decreased by 27 percent.
More articles on ASC news:
SCA launches secondary public offering of common stock
New Tenet & USPI JV, SCA public offering, MFC financial results & more – 7 recent ASC company key notes
OIG: Reducing HOPD reimbursement on ASC-approved procedures could save $15B over 5 years
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
